tiprankstipranks
Trending News
More News >
Biosyent Inc (TSE:RX)
:RX
Canadian Market

Biosyent (RX) Cash flow

Compare
51 Followers

Biosyent Cash Flow

TSE:RX's free cash flow for Q3 2025 was C$2.53M. For the 2025 fiscal year, TSE:RX's free cash flow was decreased by C$-886.91K and operating cash flow was C$2.77M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ 8.66MC$ 5.05MC$ 4.95MC$ 4.67MC$ 6.89M
Investing Cash Flow
C$ 3.29MC$ 883.85KC$ -10.79MC$ -4.84MC$ 3.39M
Financing Cash Flow
C$ -7.83MC$ -5.78MC$ -4.37MC$ -2.08MC$ -3.37M
End Cash Position
C$ 12.11MC$ 7.98MC$ 7.86MC$ 18.04MC$ 20.29M
Free Cash Flow
C$ 3.99MC$ 4.88MC$ 4.43MC$ 4.58MC$ 6.72M
Currency in CAD

Biosyent Cash Flow